Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
Claudia M. Denkinger(Heidelberg University), Michael Schmitt(German Cancer Research Center), Michael Kreuter(Johannes Gutenberg University Mainz), Julia Gall(German Cancer Research Center), Johannes Krisam(University Hospital Heidelberg), Ralf Bartenschlager(German Cancer Research Center), Paul Schnitzler(Heidelberg University), Anke Morgner(Klinikum Chemnitz), Maike Janssen(Heidelberg University), Cihan Celik(Klinikum Darmstadt), Felix Herth(Heidelberg University), Martin Bornhäuser(Technische Universität Dresden), Lukas Baumann(Statistics Austria), Carl Christoph Schimanski(Johannes Gutenberg University Mainz), Mary Gaeddert(Heidelberg University), Hans‐Georg Kräusslich(Heidelberg University), Lars Bullinger(Stanford University), Olaf Hopfer(Goethe University Frankfurt), Ulrike Schäkel(Health First), Marylyn M. Addo(Universität Hamburg), Michael Kiehl(Klinikum Frankfurt Höchst), Uta Merle(Heidelberg University), Bernd Hertenstein(San Antonio College), Phil‐Robin Tepasse(University Hospital Münster), Mathias Hänel(Klinikum Chemnitz), Nael Alakel(University Hospital Carl Gustav Carus), Niels Halama(German Cancer Research Center), Stefan Schmiedel(Universität Hamburg), Sylvia Parthé(Heidelberg University), Maria J. G. T. Vehreschild(Goethe University Frankfurt), Jennifer Klemmer(Heidelberg University), Winfried V. Kern(University Medical Center Freiburg), Jens Schrezenmeier(Charité - Universitätsmedizin Berlin), Christian Nußhag, Margarida Souto‐Carneiro(Heidelberg University), Hanns‐Martin Lorenz, Jacek Stermann(Heidelberg University), Patrick Stelmach(German Cancer Research Center), Oliver Witzke(Essen University Hospital), Mohammad-Amen Wattad, Bárbara Müller(Heidelberg University), Martina Gronkowski(Heidelberg University), Stefan Weber(Heidelberg University), Markus A. Weigand(Heidelberg University), Anita Schmitt(Heidelberg University), Stefan Meuer(Johannes Gutenberg University Mainz), Albrecht Leo, Timo Wolf(Goethe University Frankfurt), Matthias Ruhe(Herford Hospital), Thorsten Pohle(Herford Hospital)
Cited by 62
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k